News & Updates

Show Multimedia Only
How effective is ensovibep in hospitalized adults with COVID-19?

How effective is ensovibep in hospitalized adults with COVID-19?

16 Aug 2022 byStephen Padilla

Hospitalized patients with COVID-19 who are receiving remdesivir and other standard care show no improvements in clinical outcomes with the addition of ensovibep, according to the results of a study.

How effective is ensovibep in hospitalized adults with COVID-19?

16 Aug 2022
Does TB influence viral suppression in HIV patients on DTG-based therapy?

Does TB influence viral suppression in HIV patients on DTG-based therapy?

16 Aug 2022 byAudrey Abella

Incident tuberculosis (TB) appears to be a risk factor for virologic non-suppression (ie, viral load of >1,000 copies/mL) in HIV patients who have transitioned to dolutegravir (DTG)-based therapy with recycled NRTIs*, according to a retrospective subanalysis of the VISEND study.

Does TB influence viral suppression in HIV patients on DTG-based therapy?

16 Aug 2022
HCV reinfection highest among people with ongoing injecting drug use

HCV reinfection highest among people with ongoing injecting drug use

14 Aug 2022

Reinfection with hepatitis C virus (HCV) is low among people receiving opioid agonist therapy (OAT) but appears to be at its peak during the first 24 weeks following treatment completion and among those with ongoing injecting drug use and needle‒syringe sharing, a study has found.

HCV reinfection highest among people with ongoing injecting drug use

14 Aug 2022
Another breakthrough for HIV: Fourth patient goes into long-term remission

Another breakthrough for HIV: Fourth patient goes into long-term remission

12 Aug 2022
MRNA shots effective against COVID-19 Delta variant

MRNA shots effective against COVID-19 Delta variant

11 Aug 2022
1 week off methotrexate works okay for RA patients receiving flu shot

1 week off methotrexate works okay for RA patients receiving flu shot

11 Aug 2022
Coronavirus surrogates may stay on meat, fish in cold storage for up to a month

Coronavirus surrogates may stay on meat, fish in cold storage for up to a month

10 Aug 2022 byAudrey Abella

Surrogates of SARS-CoV-2* – a lipid enveloped RNA bacteriophage (Phi6) and two animal coronaviruses (CoVs; MHV and TGEV**) – survived in cold-storage temperatures for 30 days, a study finds, highlighting the risk of viral survival on food products and potential transmission on humans upon consumption.

Coronavirus surrogates may stay on meat, fish in cold storage for up to a month

10 Aug 2022